The distinction at the Disruptores Innovation Awards 2026, presented by the Spanish media outlet El Español, recognises SPEEDCELL as Best Research Project.
The European project SPEEDCELL has received the Best Research Project award at the Disruptores Innovation Awards 2026, held at the Palacio de Neptuno in Madrid. The initiative aims to accelerate the development and manufacturing of biological products and vaccines in just 100 days, strengthening Europe’s ability to respond to future global health emergencies.
This recognition reflects years of teamwork, perseverance and dedication from a large number of people. The awards recognise projects, companies and professionals within the technology ecosystem who are driving digital transformation across key sectors of the economy.
Laura Ferrer, R&D Director Human Health at HIPRA, has also been named Researcher of the Year. Throughout her career spanning more than 25 years, she has helped advance research and development through innovative solutions in both animal and human health. She currently leads a team of more than 70 people, which has achieved several scientific milestones, including leading the European SPEEDCELL project and developing the first COVID-19 vaccine to receive prequalification from the World Health Organization (WHO).
Ferrer received the award alongside other scientific representatives, including María Puertas Bartolomé, Isabel Abánades, Antoni Forner and Borja Peropadre. The award was presented to her by Fernando Suárez, President of the Spanish Council of Colleges of Computer Engineering (CCII).
In Laura Ferrer’s words: “At HIPRA, we firmly believe that investing in science and innovation is the best way to prepare for the healthcare challenges of the future. We want to continue developing solutions that have a real impact on global health and contribute to strengthening Europe’s scientific and industrial capabilities.”
